Toronto Dominion Bank
NKTR icon

Toronto Dominion Bank’s Nektar Therapeutics NKTR Stock Holding History

Toronto Dominion Bank’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1
Closed – – 1691
2023
Q1 		$0 Buy
+1
New +$30 ﹤0.01% 1627
2022
Q3 		– Sell
-1
Closed – – 1663
2022
Q2 		$0 Hold
1
– – ﹤0.01% 1694
2022
Q1 		$0 Hold
1
– – ﹤0.01% 1793
2021
Q4 		$0 Buy
+1
New +$217 ﹤0.01% 1831
2021
Q1 		– Hold
0
– – – 1529
2020
Q4 		– Hold
0
– – – 1409
2020
Q3 		– Hold
0
– – – 1310
2020
Q2 		– Hold
0
– – – 1323
2020
Q1 		– Hold
0
– – – 1380
2019
Q4 		– Sell
-8,594
Closed -$2.49M – 1485
2019
Q3 		$2.35M Sell
8,594
-7,842
-48% -$2.88M ﹤0.01% 788
2019
Q2 		$4.39M Buy
16,436
+8,382
+104% +$4.2M 0.01% 691
2019
Q1 		$4.06M Buy
8,054
+1,169
+17% +$693K 0.01% 727
2018
Q4 		$3.39M Sell
6,885
-580
-8% -$350K 0.01% 712
2018
Q3 		$6.83M Buy
7,465
+561
+8% +$479K 0.01% 608
2018
Q2 		$5.06M Buy
6,904
+1,853
+37% +$2.14M 0.01% 682
2018
Q1 		$8.05M Buy
+5,051
New +$6.51M 0.02% 471

Other funds holding NKTR

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Toronto Dominion Bank's NKTR Position: Q2 2023 in Review

Toronto Dominion Bank sold out of Nektar Therapeutics (NKTR) in Q2 2023, closing a stake of 1 share.

Toronto Dominion Bank first reported a position in NKTR in Q1 2018 and held it in 11 quarters. The position peaked at $8.05M in Q1 2018. 146 funds tracked by Wall St. Rank hold NKTR as of Q2 2023.

  • Toronto Dominion Bank reported no remaining Nektar Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Toronto Dominion Bank sold 1 Nektar Therapeutics share in Q2 2023.
  • Toronto Dominion Bank first reported a position in Nektar Therapeutics in Q1 2018 and held it in 11 quarters.
  • Toronto Dominion Bank's Nektar Therapeutics position peaked at $8.05M in Q1 2018.
  • 146 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2023.

Based on Toronto Dominion Bank's 13F filing for Q2 2023, filed 10 Aug 2023.